Efficacy and Impact of a Comprehensive Smoking Cessation Intervention During Radiation for Upper Aerodigestive Cancers
Sponsor study identifier
Secondary identifiers
OTHER · JHM IRB
NIH
interventional
30
1 country
1
Study Start
May 2014
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
May 2015
Actual (reported)Study Completion
May 2016
Actual (reported)Smoking is the greatest risk factor for upper aerodigestive cancers (thoracic or head and neck) and negatively impacts survival and other outcomes, but many patients have difficulty quitting after their diagnosis. Smoking cessation interventions for cancer patients thus far have had limited success. This is a pilot randomized controlled trial designed to determine if a new comprehensive, evidence-based smoking cessation intervention can improve quit rates for cancer patients who smoke.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
May 2016
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 2014
Date type not reportedThis date has not been verified as actual or estimated.
July 7, 2014
Actual (reported)July 11, 2014
Actual (reported)May 2015
Actual (reported)May 2016
Actual (reported)Smoking cessation
Smoking cessation will be defined as BOTH (1) self-reported 7-day abstinence from smoking and (2) exhaled carbon monoxide level of 8 or lower as biochemical confirmation of abstinence.
8 weeks
New evidence-based comprehensive smoking cessation intervention including several elements that have proven successful in non-cancer patients but not used for cancer patients before.
Intervention consistent with the U.S. Department of Health and Human Services guidelines for tobacco treatment.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Johns Hopkins Medicine
Baltimore, Maryland, 21287, United States
Holliday R, Hong B, McColl E, Livingstone-Banks J, Preshaw PM. Interventions for tobacco cessation delivered by dental professionals. Cochrane Database Syst Rev. 2021 Feb 19;2(2):CD005084. doi: 10.1002/14651858.CD005084.pub4.
Gypsyamber D'Souza, PhD
Johns Hopkins Bloomberg School of Public Health, Department of Epidemiology
30 participants (actual enrollment reported by the registry).
First Submitted
July 7, 2014
First Posted
July 11, 2014
Study Start
May 2014
Date type not reportedThis date has not been verified as actual or estimated.
Medicinal Nicotine for Preventing Cue Induced Craving
Contact the study team to confirm eligibility.
Primary Completion
May 2015
Actual (reported)Study Completion
May 2016
Actual (reported)Last Updated
January 17, 2019
Record last verified: 2015-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: